Inquiry : a journal of medical care organization, provision and financing
Jan 1, 2024
The increasing integration of Artificial Intelligence (AI) in the medical domain signifies a transformative era in healthcare, with promises of improved diagnostics, treatment, and patient outcomes. However, this rapid technological progress brings a...
Artificial intelligence (AI) can enhance life experiences and present challenges for people with disabilities. This study aims to investigate the relationship between AI and disability, exploring the potential benefits and challenges of using AI fo...
Information on the application of artificial intelligence (AI) in healthcare is needed to align healthcare transformation efforts. This bibliometric analysis aims to establish the patterns of publication activities on the application of AI in health....
Advances in experimental medicine and biology
Jan 1, 2024
This chapter primarily focuses on the progress in depression precision medicine with specific emphasis on the integrative approaches that include artificial intelligence and other data, tools, and technologies. After the description of the concept of...
Advances in experimental medicine and biology
Jan 1, 2024
The chapter provides an in-depth analysis of digital therapeutics (DTx) as a revolutionary approach to managing major depressive disorder (MDD). It discusses the evolution and definition of DTx, their application across various medical fields, regula...
The second part of the literature review on the application of artificial intelligence (AI) methods for screening, diagnosing, monitoring, and treating glaucoma provides information on how AI methods enhance the effectiveness of glaucoma monitoring a...
OBJECTIVES: In solving the trust issues surrounding machine learning algorithms whose reasoning cannot be understood, advancements can be made toward the integration of machine learning algorithms into mHealth applications. The aim of this paper is t...
Technology in cancer research & treatment
Jan 1, 2024
The programmed cell death protein 1 (PD-1, CD279) is an important therapeutic target in many oncological diseases. This checkpoint protein inhibits T lymphocytes from attacking other cells in the body and thus blocking it improves the clearance of tu...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.